Trial Profile
Phase II trial of darleukin in combination with fibromun in head and neck cancer patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2016
Price :
$35
*
At a glance
- Drugs Bifikafusp alfa (Primary) ; Onfekafusp alfa
- Indications Head and neck cancer
- Focus Therapeutic Use
- Sponsors Philogen
- 21 Jan 2016 New trial record